Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
Abstract Metaplastic breast carcinoma (MpBC) is a rare special histologic subtype of breast carcinoma characterized by the presence of squamous and/or mesenchymal differentiation. Most MpBCs are of triple-negative phenotype and neoadjuvant chemotherapy (NAC) is frequently utilized in patients with M...
Main Authors: | Willard Wong, Edi Brogi, Jorge S. Reis-Filho, George Plitas, Mark Robson, Larry Norton, Monica Morrow, Hannah Y. Wen |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-07-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-021-00302-z |
Similar Items
-
Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy
by: Anne Grabenstetter, et al.
Published: (2022-08-01) -
HER2-Positive Metaplastic Breast Cancer with Resistance to Neoadjuvant Chemotherapy: Case Report
by: Kaho Tateishi, et al.
Published: (2023-11-01) -
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
by: Lea A. Moukarzel, et al.
Published: (2021-04-01) -
TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer
by: Edaise M. da Silva, et al.
Published: (2021-04-01) -
Metaplastic carcinoma of breast
by: N Dewasi, et al.
Published: (2014-04-01)